New website about primary nocturnal enuresis opened in Scandinavia
Copenhagen, Denmark – 3 March, 2003 –
Ferring Pharmaceuticals is proud to announce the launch of the website www.dryallnight.com.
The site is available in the Scandinavian languages, Danish, Norwegian, Swedish and Finnish and is intended to function as a one-stop information resource for parents, teachers and health professionals with respect to primary nocturnal enuresis (bedwetting). The information on the site is based on knowledge from leading Scandinavian groups with enuresis expertise.
Over 200.000 Scandinavian children have problems with bedwetting. The goal of the site is to create awareness that bedwetting is a common problem which can be treated promptly and effectively.
About Ferring Pharmaceuticals
Ferring is a research driven, speciality biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of urology, obstetrics and infertility, gastroenterology and endocrinology. In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.
To learn more about Ferring or our products please visit us at www.Ferring.com.
For more information, please contact
Karsten Lauridsen
Ferring Lægemidler
+45 28 95 96 22
karsten.lauridsen@ferring.com
